Ceapro to Partner with McMaster University
EDMONTON, AB: One of the growing biotechnology company Ceapro, announced an extensive research program in collaboration with McMaster University to develop novel chemistries for stabilizing Ceapro’s Pressurized Gas eXpanded (PGX) derived products. McMaster University researchers were awarded a $370,300 research grant from Natural Sciences and Engineering Research Council of Canada to advance Ceapro’s application of its PGX Technology research partnership.
The research collaboration is a three-year agreement in which Ceapro will host and train graduate students and process material with PGX in its Edmonton-based laboratories. Using Ceapro’s PGX technology, the study will focus on the development and application of highly tunable porous biopolymer and smart polymer scaffolds. With the considerable potential to develop and expand the utility of PGX Technology and open new market opportunities through proof-of-concept demonstrations of applications of the PGX material, Ceapro will provide financial support to match the award received by McMaster University.
Commencing in the first half of 2016, the research collaboration with McMaster University aims to develop novel chemistries for stabilizing PGX-derived products based on sustainable biopolymers and “smart” environmentally-responsive polymers that change properties in response to an environmental stimulus. By the combined expertise of the Hoare lab in bioactives delivery and tissue engineering and the Latulippe lab in bioseparations and environmental adsorption technologies, these novel chemistries will then be leveraged. This can improve delivery of drugs and agricultural chemicals, generate 3D cell scaffolds maintaining high cell viability, generate low-cost alternatives for purification of antibodies and viruses, improve methods of removing heavy metal ions from industrial waste water, and enhance the capture of carbon dioxide from polluted air.
With several key advantages over conventional drying and purification technologies that can be used to process biopolymers into high-value, nano-sized polymer structures and novel bio-nanocomposites, PGX is a unique and disruptive technology.
Based out of Canada, Ceapro is a company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. With a broad range of expertise, Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical and therapeutic products for humans and animals.